Follow
Camilla Worsfold
Camilla Worsfold
Adeptrix Corp.
Verified email at adeptrix.com
Title
Cited by
Cited by
Year
Complementary PTM profiling of drug response in human gastric carcinoma by immunoaffinity and IMAC methods with total proteome analysis
MP Stokes, CL Farnsworth, H Gu, X Jia, CR Worsfold, V Yang, JM Ren, ...
Proteomes 3 (3), 160-183, 2015
412015
Affinity-bead assisted mass spectrometry (Affi-BAMS): a multiplexed microarray platform for targeted proteomics
GM Hamza, VB Bergo, S Mamaev, DM Wojchowski, P Toran, CR Worsfold, ...
International Journal of Molecular Sciences 21 (6), 2016, 2020
122020
A targeted multiplexed MALDI MS assay platform using affinity-bead assisted mass spectrometry (Affi-BAMS) for monitoring brain and CSF biomarkers
JC Silva, S Dikler, S Mamaev, C Worsfold, A Moghekar, T Wiederhold, ...
Journal of biomolecular techniques: JBT 31 (Suppl), S28, 2020
22020
Multiplexed analytical platform using affinity capture and MALDI MS enables novel assay development for screening Biomarkers in neurological diseases
VB Bergo, GM Hamza, S Dikler, A Moghekar, M Askenazi, ...
Proceedings of the 68th ASMS Conference on Mass Spectrometry and Allied …, 2020
22020
Affi-BAMS™: A Robust Targeted Proteomics Microarray Platform to Measure Histone Post-Translational Modifications
GM Hamza, E Miele, DM Wojchowski, P Toran, CR Worsfold, ...
International Journal of Molecular Sciences 24 (12), 10060, 2023
2023
BAMS: A Robust Analytical Platform for Quantifying Histone Modifications and Various Proteoforms by IP MALDI MS
GM Hamza, E Miele, D Wojchowski, C Worsfold, TS Anthonymuthu, ...
Molecular & Cellular Proteomics 21 (8), S56-S56, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–6